Interested in participating in a national pharmacist-led medication adherence study and getting paid to participate?
Your participation in this national study could highlight your pharmacists' unique role and expertise within your institution, help increase your patients' medication adherence, and serve to demonstrate the impact of hospital and health-system pharmacists' motivational interviewing on health outcomes through real-world clinical and economic data.
Become a Participating Site
Steps:
- Contact PMAPP Team at inquiry@p-mapp.com to express your interest
- Discuss with PMAPP Team to determine if your site meets the study criteria
- Receive approval from the PMAPP Team
- Determine if study protocol will need to go through your IRB approval process
- Work with the PMAPP Team to enroll patients. The step-by-step workflow process can be found on the P-MAPP website.
About the Study
The Personalized-Medication Adherence and Persistence Program (P-MAPP) study is the first national initiative built in collaboration with patients, prescribers, pharmacists, industry, payers, and regulators that impacts real-world clinical and economic outcomes for patients with Type 2 Diabetes. Established under a Research Collaboration Agreement with the U.S. Food and Drug Administration (FDA), the P-MAPP links comprehensive longitudinal patient-centric data, acquired in the "voice of the patient" via customized surveys, with information contained in patients' health records, pharmacy fill/refill information and medical claims to create a de-identified, aggregated database of real world medication adherence/persistence and clinical outcomes.
Get Involved
If you are interested in learning more about the P-MAPP study or participating in it, please contact inquiry@p-mapp.com. For more information including frequently asked questions, please visit the P-MAPP website.
Should you have any questions for ASHP related to this opportunity, please direct your inquiry to practiceadvancement@ashp.org.
Disclaimer: ASHP does not have a business affiliation with P-MAPP or any of its sponsors or collaborators. However, ASHP supports the mission of P-MAPP, and as such, has identified your organization as a potential candidate for this national study based on its practice model and its inclusion and support of pharmacists who specialize in the area of diabetes and comprehensive medication management. Those organizations choosing to participate in the program will receive remuneration.